Company: APM
Filing Date: 2025-01-03
Form Type: 424B5
Source: 0001213900-25-000606
Chunk: 5

Company: Aptorum Group Ltd
Filing Date: 2025-01-03
Form: 424B5
Chunk 5
---
 of assumptions underlying any of the foregoing. The words “believe,”
“anticipate,” “estimate,” “plan,” “expect,” “intend,” “may,” “could,”
“should,” “potential,” “likely,” “projects,” “continue,” “will,”
and “would” and similar expressions are intended to identify forward-looking statements, although not all forward-looking
statements contain these identifying words. Forward-looking statements reflect our current views with respect to future events, are based
on assumptions and are subject to risks and uncertainties. We cannot guarantee that we actually will achieve the plans, intentions or
expectations expressed in our forward-looking statements and you should not place undue reliance on these statements. There are a number
of important factors that could cause our actual results to differ materially from those indicated or implied by forward-looking statements.
These important factors include those discussed under the heading “Risk Factors” contained or incorporated by reference in
this prospectus and in the applicable prospectus supplement and any free writing prospectus we may authorize for use in connection with
a specific offering. These factors and the other cautionary statements made in this prospectus should be read as being applicable to all
related forward-looking statements whenever they appear in this prospectus. You are cautioned not to place undue reliance on the forward-looking
statements contained in, or incorporated by reference into, this prospectus supplement. Each forward-looking statement speaks only as
of the date this prospectus supplement or, in the case of documents incorporated by reference, the date of the applicable document (or
any earlier date indicated in the statement), and except as required by law, we undertake no obligation to update publicly any forward-looking
statements, whether as a result of new information, future events or otherwise. We qualify all such forward-looking statements by these
cautionary statements.

<div align='center'>S-iii

PROSPECTUS SUPPLEMENT SUMMARY</div>

The following summary highlights
selected information contained or incorporated by reference in this prospectus supplement. This summary does not contain all of the information
you should consider before investing in the securities. Before making an investment decision, you should read the entire prospectus and
any supplement hereto carefully, including the risk factors section, the financial statements and the notes to the financial statements
incorporated herein by reference, and the documents that we incorporate by reference herein.

Our Business

We are a clinical stage biopharmaceutical
company dedicated to the discovery, development, and commercialization of therapeutic assets